Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2035

1.

Consensus Recommendations for the Clinical Management of Patients With Multiple Myeloma Treated With Selinexor.

Mikhael J, Noonan KR, Faiman B, Gleason C, Nooka AK, Costa LJ, Jagannath S, Richardson PG, Siegel D, Chari A, Lentzch S.

Clin Lymphoma Myeloma Leuk. 2020 Mar 7. pii: S2152-2650(20)30011-2. doi: 10.1016/j.clml.2019.12.026. [Epub ahead of print] No abstract available.

PMID:
32245742
2.

Post-traumatic stress disorder is associated with further increased Parkinson's disease risk in veterans with traumatic brain injury.

White DL, Kunik ME, Yu H, Lin HL, Richardson PA, Moore S, Sarwar AI, Marsh L, Jorge RE.

Ann Neurol. 2020 Mar 30. doi: 10.1002/ana.25726. [Epub ahead of print]

PMID:
32232880
3.

Defibrotide formulations contain (1→3)-β-D-glucan that could influence clinical diagnostic testing.

Alosaimy S, Nauffal M, Soiffer R, Glotzbecker B, Kubiak DW, Richardson P, Marty FM, Koo S, McDonnell AM.

Bone Marrow Transplant. 2020 Mar 30. doi: 10.1038/s41409-020-0872-y. [Epub ahead of print] No abstract available.

PMID:
32231251
4.

Investigating the distribution and regional occurrence of anthropogenic litter in English marine protected areas using 25 years of citizen-science beach clean data.

Nelms SE, Eyles L, Godley BJ, Richardson PB, Selley H, Solandt JL, Witt MJ.

Environ Pollut. 2020 Mar 13;263(Pt B):114365. doi: 10.1016/j.envpol.2020.114365. [Epub ahead of print]

PMID:
32220688
5.

Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study.

Richardson PG, Bringhen S, Voorhees P, Plesner T, Mellqvist UH, Reeves B, Paba-Prada C, Zubair H, Byrne C, Chauhan D, Anderson K, Nordström E, Harmenberg J, Palumbo A, Sonneveld P.

Lancet Haematol. 2020 Mar 23. pii: S2352-3026(20)30044-2. doi: 10.1016/S2352-3026(20)30044-2. [Epub ahead of print]

PMID:
32213344
6.

Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes With Defibrotide Following Hematopoietic Cell Transplantation in Adult and Pediatric Patients.

Corbacioglu S, Kernan NA, Pagliuca A, Ryan RJ, Tappe W, Richardson PG.

Biol Blood Marrow Transplant. 2020 Mar 18. pii: S1083-8791(20)30148-8. doi: 10.1016/j.bbmt.2020.03.011. [Epub ahead of print]

7.

Effects of Mydriatics on Rod/Cone- and Melanopsin-driven Pupil Responses.

Flanagan SC, Saunders KJ, Queener HM, Richardson P, Ostrin LA.

Optom Vis Sci. 2020 Mar;97(3):198-206. doi: 10.1097/OPX.0000000000001486.

PMID:
32168243
8.

Pooled analysis of Day 100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantation.

Richardson PG, Smith AR, Kernan NA, Lehmann L, Soiffer RJ, Ryan RJ, Tappe W, Grupp S.

Br J Haematol. 2020 Mar 10. doi: 10.1111/bjh.16552. [Epub ahead of print]

PMID:
32157682
9.

Endocannabinoids in aqueous humour of patients with or without diabetes.

Richardson P, Ortori C, Barrett D, O'Sullivan S, Idris I.

BMJ Open Ophthalmol. 2020 Feb 17;5(1):e000425. doi: 10.1136/bmjophth-2019-000425. eCollection 2020.

10.

Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd.

Chari A, Richardson PG, Romanus D, Dimopoulos MA, Sonneveld P, Terpos E, Hajek R, Raju A, Palumbo A, Cain LE, Blazer M, Huang H, Farrelly E, Ailawadhi S.

Expert Rev Hematol. 2020 Apr;13(4):421-433. doi: 10.1080/17474086.2020.1729734. Epub 2020 Mar 9.

PMID:
32148109
11.

c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma.

Di Bacco A, Bahlis NJ, Munshi NC, Avet-Loiseau H, Masszi T, Viterbo L, Pour L, Ganly P, Cavo M, Langer C, Kumar SK, Rajkumar SV, Keats JJ, Berg D, Lin J, Li B, Badola S, Shen L, Zhang J, Esseltine DL, Luptakova K, van de Velde H, Richardson PG, Moreau P.

Eur J Haematol. 2020 Mar 7. doi: 10.1111/ejh.13405. [Epub ahead of print]

PMID:
32145111
12.

Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment.

Richardson PG, Corbacioglu S.

Blood Cancer J. 2020 Mar 4;10(3):29. doi: 10.1038/s41408-020-0286-5. No abstract available.

13.

Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma.

Rowinsky EK, Paner A, Berdeja JG, Paba-Prada C, Venugopal P, Porkka K, Gullbo J, Linder S, Loskog A, Richardson PG, Landgren O.

Invest New Drugs. 2020 Mar 3. doi: 10.1007/s10637-020-00915-4. [Epub ahead of print]

PMID:
32125598
14.

COVID-19: combining antiviral and anti-inflammatory treatments.

Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P.

Lancet Infect Dis. 2020 Apr;20(4):400-402. doi: 10.1016/S1473-3099(20)30132-8. Epub 2020 Feb 27. No abstract available.

PMID:
32113509
15.

Rapid 13C NMR hyperpolarization delivered from para-hydrogen enables the low concentration detection and quantification of sugars.

Richardson PM, Iali W, Roy SS, Rayner PJ, Halse ME, Duckett SB.

Chem Sci. 2019 Sep 24;10(45):10607-10619. doi: 10.1039/c9sc03450a. eCollection 2019 Dec 7.

16.

Lumbar arachnoiditis: Does imaging associate with clinical features?

Parenti V, Huda F, Richardson PK, Brown D, Aulakh M, Taheri MR.

Clin Neurol Neurosurg. 2020 Feb 3;192:105717. doi: 10.1016/j.clineuro.2020.105717. [Epub ahead of print]

PMID:
32062307
17.

RASS-Enabled S/P-C and S-N Bond Formation for DEL Synthesis.

Flood DT, Zhang X, Fu X, Zhao Z, Asai S, Sanchez BB, Sturgell EJ, Vantourout JC, Richardson P, Flanagan ME, Piotrowski DW, Kölmel DK, Wan J, Tsai MH, Chen JS, Baran PS, Dawson PE.

Angew Chem Int Ed Engl. 2020 Feb 12. doi: 10.1002/anie.201915493. [Epub ahead of print]

PMID:
32050046
18.

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?

Plesner T, van de Donk N, Richardson PG.

Cells. 2020 Feb 6;9(2). pii: E378. doi: 10.3390/cells9020378.

19.

Indications of Susceptibility to Calonectria pseudonaviculata in Some Common Groundcovers and Boxwood Companion Plants.

Richardson PA, Daughtrey M, Hong C.

Plant Dis. 2020 Apr;104(4):1127-1132. doi: 10.1094/PDIS-08-19-1582-RE. Epub 2020 Feb 10.

PMID:
32040391
20.

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.

Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Stebbing J.

Lancet. 2020 Feb 15;395(10223):e30-e31. doi: 10.1016/S0140-6736(20)30304-4. Epub 2020 Feb 4. No abstract available.

PMID:
32032529
21.

Isotopically Directed Symmetry Breaking and Enantioenrichment in Attrition-Enhanced Deracemization.

Murray JI, Sanders JN, Richardson PF, Houk KN, Blackmond DG.

J Am Chem Soc. 2020 Feb 26;142(8):3873-3879. doi: 10.1021/jacs.9b11422. Epub 2020 Feb 17.

PMID:
32027134
22.

Selinexor for the treatment of multiple myeloma.

Podar K, Shah J, Chari A, Richardson PG, Jagannath S.

Expert Opin Pharmacother. 2020 Mar;21(4):399-408. doi: 10.1080/14656566.2019.1707184. Epub 2020 Jan 19.

PMID:
31957504
23.

Symptom changes and crack progression in untreated cracked teeth: One-year findings from the National Dental Practice-Based Research Network.

Hilton TJ, Funkhouser E, Ferracane JL, Gilbert GH, Gordan VV, Bennett S, Bone J, Richardson PA, Malmstrom H; National Dental PBRN Collaborative Group.

J Dent. 2020 Feb;93:103269. doi: 10.1016/j.jdent.2019.103269. Epub 2019 Dec 30.

PMID:
31899264
24.

Factors Related to Agreement Between Child and Caregiver Report of Child Functioning With Chronic Pain: PROMIS Pediatric and Parent Proxy Report.

Birnie KA, Richardson PA, Rajagopalan AV, Bhandari RP.

Clin J Pain. 2020 Mar;36(3):203-212. doi: 10.1097/AJP.0000000000000794.

PMID:
31876791
25.

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.

Lonial S, Lee HC, Badros A, Trudel S, Nooka AK, Chari A, Abdallah AO, Callander N, Lendvai N, Sborov D, Suvannasankha A, Weisel K, Karlin L, Libby E, Arnulf B, Facon T, Hulin C, Kortüm KM, Rodríguez-Otero P, Usmani SZ, Hari P, Baz R, Quach H, Moreau P, Voorhees PM, Gupta I, Hoos A, Zhi E, Baron J, Piontek T, Lewis E, Jewell RC, Dettman EJ, Popat R, Esposti SD, Opalinska J, Richardson P, Cohen AD.

Lancet Oncol. 2020 Feb;21(2):207-221. doi: 10.1016/S1470-2045(19)30788-0. Epub 2019 Dec 16.

PMID:
31859245
26.

The Detection and Reactivity of Silanols and Silanes Using Hyperpolarized 29 Si Nuclear Magnetic Resonance.

Rayner PJ, Richardson PM, Duckett SB.

Angew Chem Int Ed Engl. 2020 Feb 10;59(7):2710-2714. doi: 10.1002/anie.201915098. Epub 2020 Jan 9.

27.

Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement.

Mahadeo KM, Bajwa R, Abdel-Azim H, Lehmann LE, Duncan C, Zantek N, Vittorio J, Angelo J, McArthur J, Schadler K, Chan S, Tewari P, Khazal S, Auletta JJ, Choi SW, Shoberu B, Kalwak K, Harden A, Kebriaei P, Abe JI, Li S, Moffet JR, Abraham S, Tambaro FP, Kleinschmidt K, Richardson PG, Corbacioglu S; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network and the Pediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation.

Lancet Haematol. 2020 Jan;7(1):e61-e72. doi: 10.1016/S2352-3026(19)30201-7. Epub 2019 Dec 7. Review.

PMID:
31818728
28.

Understanding substrate substituent effects to improve catalytic efficiency in the SABRE hyperpolarisation process.

Stanbury EV, Richardson PM, Duckett SB.

Catal Sci Technol. 2019 Aug 7;9(15):3914-3922. doi: 10.1039/c9cy00396g. Epub 2019 Jul 10.

29.

In Situ SABRE Hyperpolarization with Earth's Field NMR Detection.

Hill-Casey F, Sakho A, Mohammed A, Rossetto M, Ahwal F, Duckett SB, John RO, Richardson PM, Virgo R, Halse ME.

Molecules. 2019 Nov 14;24(22). pii: E4126. doi: 10.3390/molecules24224126.

30.

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study.

Attal M, Richardson PG, Rajkumar SV, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Macé S, Corzo KP, Campana F, Le-Guennec S, Dubin F, Anderson KC; ICARIA-MM study group.

Lancet. 2019 Dec 7;394(10214):2096-2107. doi: 10.1016/S0140-6736(19)32556-5. Epub 2019 Nov 14. Erratum in: Lancet. 2019 Dec 7;394(10214):2072.

PMID:
31735560
31.

Randomized Clinical Trial Representativeness and Outcomes in Real-World Patients: Comparison of 6 Hallmark Randomized Clinical Trials of Relapsed/Refractory Multiple Myeloma.

Chari A, Romanus D, Palumbo A, Blazer M, Farrelly E, Raju A, Huang H, Richardson P.

Clin Lymphoma Myeloma Leuk. 2020 Jan;20(1):8-17.e16. doi: 10.1016/j.clml.2019.09.625. Epub 2019 Oct 10.

32.

Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.

Lewis C, Kim HT, Roeker LE, Cutler C, Koreth J, Nikiforow S, Armand P, Gootpu M, Romee R, Glotzbecker B, Nageshwar P, Antin JH, Alyea EP, Richardson P, Soiffer RJ, Ho VT.

Biol Blood Marrow Transplant. 2020 Mar;26(3):529-539. doi: 10.1016/j.bbmt.2019.10.024. Epub 2019 Oct 31.

PMID:
31678537
33.

A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma.

Ghobrial IM, Liu CJ, Redd RA, Perez RP, Baz R, Zavidij O, Sklavenitis-Pistofidis R, Richardson PG, Anderson KC, Laubach J, Henrick P, Savell A, Reyes K, Hornburg K, Chuma S, Sabbatini P, Robbins MD, Becker PS.

Clin Cancer Res. 2020 Jan 15;26(2):344-353. doi: 10.1158/1078-0432.CCR-19-0647. Epub 2019 Oct 31.

PMID:
31672767
34.

Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease.

Awan AA, Walther CP, Richardson PA, Shah M, Winkelmayer WC, Navaneethan SD.

Nephrol Dial Transplant. 2019 Oct 22. pii: gfz192. doi: 10.1093/ndt/gfz192. [Epub ahead of print]

PMID:
31641775
35.

HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074.

Palumbo PJ, Zhang Y, Fogel JM, Guo X, Clarke W, Breaud A, Richardson P, Piwowar-Manning E, Hart S, Hamilton EL, Hoa NTK, Liulchuk M, Anandari L, Ha TV, Dumchev K, Djoerban Z, Hoffman I, Hanscom B, Miller WC, Eshleman SH.

PLoS One. 2019 Oct 10;14(10):e0223829. doi: 10.1371/journal.pone.0223829. eCollection 2019.

36.

Dropped head syndrome due to neuromuscular disorders: Clinical manifestation and evaluation.

Burakgazi AZ, Richardson PK, Abu-Rub M.

Neurol Int. 2019 Jun 19;11(3):8198. doi: 10.4081/ni.2019.8198. eCollection 2019 Sep 18.

37.

Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group.

Mohty M, Malard F, Abecasis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Basak G, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Kuball J, Lachance S, Lazarus H, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Saber W, Savani BN, Soiffer R, Styczynski J, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E.

Bone Marrow Transplant. 2020 Mar;55(3):485-495. doi: 10.1038/s41409-019-0705-z. Epub 2019 Oct 1. No abstract available.

38.

Extended Prophylaxis With Nevirapine Does Not Affect Growth in HIV-Exposed Infants.

Onyango-Makumbi C, Owora AH, Mwiru RS, Mwatha A, Young AM, Moodley D, Coovadia HM, Stranix-Chibanda L, Manji K, Maldonado Y, Richardson P, Andrew P, George K, Fawzi W, Fowler MG.

J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):377-385. doi: 10.1097/QAI.0000000000002145.

PMID:
31567725
39.

Pomalidomide in lenalidomide-refractory multiple myeloma: Far from futile.

Mo CC, Richardson PG.

Br J Haematol. 2020 Feb;188(4):483-485. doi: 10.1111/bjh.16214. Epub 2019 Sep 30. No abstract available.

PMID:
31566715
40.

Profiling Modifiable Psychosocial Factors Among Children With Chronic Pain: A Person-Centered Methodology.

Richardson PA, Birnie KA, Harrison LE, Rajagopalan A, Bhandari RP.

J Pain. 2019 Sep 12. pii: S1526-5900(19)30797-7. doi: 10.1016/j.jpain.2019.08.015. [Epub ahead of print]

PMID:
31521795
41.

Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.

Ghobrial IM, Liu CJ, Zavidij O, Azab AK, Baz R, Laubach JP, Mishima Y, Armand P, Munshi NC, Basile F, Constantine M, Vredenburgh J, Boruchov A, Crilley P, Henrick PM, Hornburg KTV, Leblebjian H, Chuma S, Reyes K, Noonan K, Warren D, Schlossman R, Paba-Prada C, Anderson KC, Weller E, Trippa L, Shain K, Richardson PG.

Am J Hematol. 2019 Nov;94(11):1244-1253. doi: 10.1002/ajh.25627. Epub 2019 Oct 4.

PMID:
31456261
42.

Best-Evidence for the Rehabilitation of Chronic Pain Part 1: Pediatric Pain.

Harrison LE, Pate JW, Richardson PA, Ickmans K, Wicksell RK, Simons LE.

J Clin Med. 2019 Aug 21;8(9). pii: E1267. doi: 10.3390/jcm8091267. Review.

43.

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.

Chari A, Vogl DT, Gavriatopoulou M, Nooka AK, Yee AJ, Huff CA, Moreau P, Dingli D, Cole C, Lonial S, Dimopoulos M, Stewart AK, Richter J, Vij R, Tuchman S, Raab MS, Weisel KC, Delforge M, Cornell RF, Kaminetzky D, Hoffman JE, Costa LJ, Parker TL, Levy M, Schreder M, Meuleman N, Frenzel L, Mohty M, Choquet S, Schiller G, Comenzo RL, Engelhardt M, Illmer T, Vlummens P, Doyen C, Facon T, Karlin L, Perrot A, Podar K, Kauffman MG, Shacham S, Li L, Tang S, Picklesimer C, Saint-Martin JR, Crochiere M, Chang H, Parekh S, Landesman Y, Shah J, Richardson PG, Jagannath S.

N Engl J Med. 2019 Aug 22;381(8):727-738. doi: 10.1056/NEJMoa1903455.

PMID:
31433920
44.

The Resident Outcome Project: Increased Academic Productivity Associated with a Formal Clinical Research Curriculum.

Miner TJ, Richardson P, Cioffi WG, Harrington DT.

J Surg Educ. 2019 Nov - Dec;76(6):e161-e166. doi: 10.1016/j.jsurg.2019.07.016. Epub 2019 Aug 3.

PMID:
31383615
45.

Alcohol-related brain injury: Improving identification and management in an acute care setting.

Owens L, Thompson A, Patterson K, Richardson P.

Future Healthc J. 2019 Mar;6(Suppl 1):84. doi: 10.7861/futurehosp.6-1-s84. No abstract available.

46.

Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis.

Forrest EH, Storey N, Sinha R, Atkinson SR, Vergis N, Richardson P, Masson S, Ryder S, Thursz MR, Allison M, Fraser A, Austin A, McCune A, Dhanda A, Katarey D, Potts J, Verma S, Parker R, Hayes PC; STOPAH NLR Group.

Aliment Pharmacol Ther. 2019 Aug;50(4):442-453. doi: 10.1111/apt.15335. Epub 2019 Jul 17.

PMID:
31313853
47.

Controlling cellular distribution of drugs with permeability modifying moieties.

Richardson PL, Marin VL, Koeniger SL, Baranczak A, Wilsbacher JL, Kovar PJ, Bacon-Trusk PE, Cheng M, Hopkins TA, Haman ST, Vasudevan A.

Medchemcomm. 2019 Apr 18;10(6):974-984. doi: 10.1039/c8md00412a. eCollection 2019 Jun 1.

PMID:
31303996
48.

Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014.

White DL, Oluyomi A, Royse K, Dong Y, Nguyen H, Chang E, Richardson P, Jiao L, Garcia JM, Kramer JR, Thrift AP, Chiao E.

J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):387-394. doi: 10.1097/QAI.0000000000002050.

PMID:
31242141
49.

Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis.

Todorović V, Su Z, Putman CB, Kakavas SJ, Salte KM, McDonald HA, Wetter JB, Paulsboe SE, Sun Q, Gerstein CE, Medina L, Sielaff B, Sadhukhan R, Stockmann H, Richardson PL, Qiu W, Argiriadi MA, Henry RF, Herold JM, Shotwell JB, McGaraughty SP, Honore P, Gopalakrishnan SM, Sun CC, Scott VE.

Sci Rep. 2019 Jun 24;9(1):9089. doi: 10.1038/s41598-019-45626-w.

50.

Strategies for the analysis of the elemental metal fraction of Ir and Ru oxides via XRD, XANES, and EXAFS.

Reksten AH, Russell AE, Richardson PW, Thompson SJ, Mathisen K, Seland F, Sunde S.

Phys Chem Chem Phys. 2019 Jun 21;21(23):12217-12230. doi: 10.1039/c9cp01758e. Epub 2019 Jun 3.

PMID:
31157341

Supplemental Content

Loading ...
Support Center